GV20 Therapeutics (https://gv20tx.com) was incorporated in 2016 with sites in Cambridge, USA, and Shanghai, China. The company utilizes high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets, and discover and develop effective antibody drugs in cancer. GV20's proprietary antibody drug discovery engine has helped establish a solid portfolio of immuno-oncology antibody drug candidates for cancer treatment.
View Top Employees from GV20 TherapeuticsWebsite | https://gv20tx.com |
Employees | 31 (19 on RocketReach) |
Founded | 2016 |
Address | 237 Putnam Ave, Cambridge, Massachusetts 02139, US |
Industry | Biotechnology Research |
Looking for a particular GV20 Therapeutics employee's phone or email?
Xiaole Liu is the CEO of GV20 Therapeutics.
19 people are employed at GV20 Therapeutics.
GV20 Therapeutics is based in Cambridge, Massachusetts.